Journal article

Publication year: 2006

Pages: 30-32

Journal: Rheumatology

Volume number: 45

ISSN: 1462-0324

eISSN: 1462-0332

Open access status: Bronze

DOI Link: https://doi.org/10.1093/rheumatology/kel288

Publisher: Oxford University Press

Abstract: 
Connective tissue diseases (CTD) such as systemic lupus erythematosus diffuse or limited systemic sclerosis and numerous others affect women frequently during the childbearing period. Every pregnancy in a patient with CTD should be regarded as high-risk pregnancy, and requires intensive monitoring and immediate treatment of clinical problems. For these reasons, for women suffering from CTD, who are pregnant or who intend to become pregnant, an interdisciplinary setting addressing all aspects of rheumatology, ob-gyn and neonatalogy needs to be provided. This setting includes particular diagnostic tools and laboratory parameters prior to and during pregnancy as well as in the post-partal period. Aside overt organ dysfunction, key problems in pregnant CTD patients consist mainly of haemostaseological problems such as antiphospholipid antibodies, neonatal lupus erythematosus, congenital heart block and drug therapy of the underlying disease, which will be outlined in this review.

Harvard Citation style: Saar, P., Hermann, W. and Muller-Ladner, U. (2006) Connective tissue diseases and pregnancy, Rheumatology, 45, pp. 30-32. https://doi.org/10.1093/rheumatology/kel288

APA Citation style: Saar, P., Hermann, W., & Muller-Ladner, U. (2006). Connective tissue diseases and pregnancy. Rheumatology. 45, 30-32. https://doi.org/10.1093/rheumatology/kel288